Back to Search
Start Over
Exploring adverse drug reactions of diabetes medicine using social media analytics and interactive visualizations
- Source :
- International Journal of Information Management. 48:228-237
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- The aim of this study is to propose an automatic and real-time social media analytics framework with interactive data visualizations to support effective exploration of knowledge about adverse drug reaction (ADR) surveillance. This proposed framework has been prototypically implemented on the basis of social media data. A longitudinal diabetes patient online community data (AskaPatient.com) as well as FDA Adverse Event Reporting Systems (FAERS) data as a benchmark were used to evaluate our proposed approach’s performance. Based on the results, our approach significantly increases the precision and accuracy for ADR extraction. The number of ADR cases, the time when the ADRs occurred, and the rating of Glucophage have been visualized that resulted by mining a collection of 870 ADRs posted in Askapatents.com over a certain time period (from 2001 to 2015). The results have important implications for pharmaceutical companies and hospitals wishing to monitor ADRs of medicines.
- Subjects :
- Computer Networks and Communications
Computer science
business.industry
05 social sciences
02 engineering and technology
Library and Information Sciences
Online community
medicine.disease
Data science
Social media analytics
Data visualization
020204 information systems
0502 economics and business
0202 electrical engineering, electronic engineering, information engineering
medicine
Glucophage
050211 marketing
Social media
Drug reaction
Adverse effect
business
Adverse drug reaction
Information Systems
Subjects
Details
- ISSN :
- 02684012
- Volume :
- 48
- Database :
- OpenAIRE
- Journal :
- International Journal of Information Management
- Accession number :
- edsair.doi...........153528f6fe160b230cc1be7576c5af24
- Full Text :
- https://doi.org/10.1016/j.ijinfomgt.2018.12.007